ciprofol
DrugThe sedation of gastrointestinal endoscopy with Ciprofol
NCT Number: NCT05518929
Ciprofol is a new general anesthetic, which combine with γ- Aminobutyric acid-a (GABAA) receptor. Ciprofol has shown equivalent anesthetic efficacy of propofol at 1/4 to 1/5 of the dosage. Ciprofol has the pharmacodynamic characteristics of rapid onset, stable and rapid recovery. Phase III clinical results showed that the incidence of injection pain and respiratory and circulatory depression of ciprofol was lower than that of propofol. Therefore, ciprofol has a good application prospect in the sedation for gastrointestinal endoscopy, especially for overweight and obese patients. We conduct a Multicenter, Randomized, Open-label, Propofol-controlled Study to Evaluate the incidence of hypoxia and severe hypoxia during Gastroenterological Endoscope sedated with CiProfol in Overweight or Obesity patients.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Phase 4
Beijing Hospital, Beijing, Beijing Municipality, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The sedation of gastrointestinal endoscopy with Ciprofol
The sedation of gastrointestinal endoscopy with Propofol
Time frame: Patients will be followed for the duration of hospital stay, an expected average of 2 hours
hypoxia( 75%≤SpO2≤89% for<60s);severe hypoxia(SpO2<75%,or SpO2<90% for >60s)
Time frame: Patients will be followed for the duration of hospital stay, an expected average of 2 hours
hypoxia( 75%≤SpO2≤89% for<60s)
Time frame: Patients will be followed for the duration of hospital stay, an expected average of 2 hours
severe hypoxemia(SpO2<75%,or SpO2<90% for >60s)
Time frame: Patients will be followed for the duration of hospital stay, an expected average of 2 hours
subclinical respiratory depression(90% ≤SpO2 ≤95% )
Time frame: Patients will be followed for the duration of hospital stay, an expected average of 2 hours
Time frame: Patients will be followed for the duration of hospital stay, an expected average of 2 hours
Patients complain pain at the site of injection or tell investigators feeling pain when they were asked before they lose consciousness.
Time frame: Patients will be followed for the duration of hospital stay, an expected average of 2 hours
Treatment of patients with hypoxia
RenJi Hospital
Other
The Incidences Of Hypoxia And Severe Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol Compared With Propofol In Overweight Or Obesity Adults Patients, A Multicenter, Randomized, Controlled Trial
Acronym: SpO2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04724291
Abdominal Pain, Digestive System Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT03609892
Chronic Gastritis, Digestive System Diseases
Xi'an, Shaanxi, China
View Trial DetailsNCT07032961
Digestive System Diseases, Digestive System Neoplasms
Guangzhou, Guangdong, China
View Trial DetailsNCT03972956
Cardiovascular Diseases, Colonic Diseases
Wuhan, Hubei, China
View Trial Details